Back to Screener

Healthcare

Solanbridge Group, Inc.(SLNX)

Live Price

Offline

$0.0001

+0.00% today

1Y Change

+400.00%

Window

Jun 23, 2025 โ†’ Jun 15, 2026

Market Cap
โ€”
Revenue Growth
0.0%
EPS Growth
0.0%
Dividend Yield
0.0%

Coverage: 246 bars ยท Jun 23, 2025 โ†’ Jun 15, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Solanbridge Group, Inc. (SLNX) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 400.0% across the available one-year price window (Jun 23, 2025 โ†’ Jun 15, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS 0.0%, free cash flow +38.7% with operating margin 0.0% and ROIC 78.7%. Stock Foundry combines SLNX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Below sector median

0.0% vs +7.6% peer median

Operating Margin

Below sector median

0.0% vs +19.4% peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

The setup is mixed rather than one-directional

Revenue is 0.0% and EPS is 0.0%, while operating margin sits near 0.0%.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

SLNX

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

SLNX Max Drawdown

0.00%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for SLNX and SPY.

Calendar-year return history is still loading or unavailable.
Solanbridge Group, Inc. logo

Company Overview

Solanbridge Group, Inc.

Other OTC

Solanbridge Group, Inc. intends to produce and sell medical marijuana in Nova Scotia, Canada. It also focuses on the development and sale of CBD-infused products in Nevada, California, and Colorado. The company was founded in 2000 and is headquartered in The Woodlands, Texas.

Leadership
David J. Cutler
IPO Date
Jun 29, 2007
Street Address
9595 Six Pines Drive
Mailing
The Woodlands, TX, 77380
Region
The Woodlands, TX, US
Reporting Currency
USD
Investor Line
832-225-1372
Last Updated
May 4, 2026
CIK: 0001165006ISIN: US83412T1043
Reports in USDSEC Registered

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
โ€”
EV/EBITDA
โ€”
Price/Sales
โ€”
Price/Book
โ€”

Growth

Revenue
0.0%
EPS
0.0%
Free Cash Flow
+38.7%

Profitability

Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
118.2%
ROIC
78.7%

Balance Sheet

Debt/Equity
โ€”
Current Ratio
0.04

Earnings Reports

No earnings data available

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.